arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Haoxi Health Technology Ltd

HAO

$0.15 0.00 (+2.12%) at close

5 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

Haoxi Health Technology Ltd demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap —

Dividend Yield —

Revenue Growth -32.4% ↘

Op. Margin -6.1% ↘

ROIC -10.6% ↘

FCF / Share $-1.44 ↘

Trailing P/E 0.1x

Price / Book 0.0x

FCF Yield —

Debt / Equity 0.09

info Valuation on last close. End-of-day price, Aug 7, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$32.80M

↓ -32.4% —

Net Income Profit after all expenses

$3.88M

↑ +200.1% —

Operating Margin Operating profit as % of sales

-6.1%

↓ -272.3% 19th

FCF / Share Free cash flow per share

$-1.44

↓ -119.3% —

Long-Term Debt Long-term obligations

$307.32K

↑ +1.9% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability →

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Revenue Growth YoY (%)	-32.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-748%)	71.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1338%)	74.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1394%)	—	—
EPS Growth YoY (%)	56.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	2550.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	300.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	200.1% Excellent ↑ Excellent Improving Year-over-year change in net income	33.2% Excellent Excellent Year-over-year change in net income	296.5% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-119.3% Weak ↑ Weak Improving Year-over-year change in free cash flow	-1874.0% Weak Weak Year-over-year change in free cash flow	-21.4% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	26.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
EPS CAGR 3Y (%)	449.6% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Operating Margin (%) (%)	-6.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	3.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-71%)	4.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-65%)	1.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-86%)	—
Effective Tax Rate (%) (%)	6.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	25.6% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.5% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	11.8% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+48%)	2.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	3.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-57%)	1.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	—
FCF Margin (%) (%)	-10.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-1.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-4.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.87x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.95x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-2.80x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Return on Invested Capital (%)	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	53.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-9.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	11.1% Good Good Operating profit relative to total assets Optimal: > 10%	26.8% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	22.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+49%)	11.5% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-24%)	61.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+313%)	-16.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Debt to Equity (x)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-31%)	—	—
Interest Coverage (x)	-43.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	41.69x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	60.47x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	1304.70x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$1.62M	$1.14M	$-442.69K	—	—
Debt / EBITDA (x)	-0.95x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.66x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.63x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Revenue per Share (USD)	$14.05	$39.64	$1.02	$0.65	—
Basic EPS, GAAP (USD)	$1.66	$1.06	$0.04	$0.01	—
Free Cash Flow per Share (USD)	$-1.44	$-0.66	$-0.03	$-0.03	—
Book Value per Share (USD)	$7.44	$9.21	$0.06	$-0.06	—
Tangible Book Value per Share (USD)	$6.67	$9.21	$0.06	$-0.06	—
Basic Weighted Avg Shares (shares)	2.33M	1.22M	27.61M	25.00M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Working Capital (USD)	$15.72M	$11.51M	$1.10M	—	—
LT Debt (USD)	$307.32K	$301.68K	$249.11K	—	—
Total Equity (USD)	$17.38M	$11.27M	$1.57M	$-1.47M	$-1.93M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Jun 30, 2025 20-F ↗	FY 2024 Jun 30, 2024 20-F ↗	FY 2023 Jun 30, 2023 20-F ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗
Sales/Revenue/Turnover (USD)	$32.80M	$48.52M	$28.23M	$16.16M	—
Depreciation Expense (USD)	$294.61K	$10.57K	$8.39K	$2.21K	—
Net Income, GAAP (USD)	$3.88M	$1.29M	$969.75K	$244.59K	—
Operating Cash Flow (USD)	$-3.36M	$-747.58K	$-872.13K	$-675.36K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 5 quarters

Haoxi Health Technology Ltd

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HAO with peers